Literature DB >> 17351727

Encephalitis lethargica following Bartonella henselae infection.

Christian Brenneis, Christoph Scherfler, Klaus Engelhardt, Raimund Helbok, Gregor Brössner, Ronny Beer, Peter Lackner, Gernot Walder, Bettina Pfausler, Erich Schmutzhard.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17351727     DOI: 10.1007/s00415-006-0319-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

Review 1.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 2.  Laboratory diagnosis of Bartonella infections.

Authors:  Brian K Agan; Matthew J Dolan
Journal:  Clin Lab Med       Date:  2002-12       Impact factor: 1.935

3.  In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.

Authors:  Carol A Glaser; Sabrina Gilliam; David Schnurr; Bagher Forghani; Somayeh Honarmand; Nino Khetsuriani; Marc Fischer; Cynthia K Cossen; Larry J Anderson
Journal:  Clin Infect Dis       Date:  2003-03-03       Impact factor: 9.079

4.  Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.

Authors:  Russell C Dale; Andrew J Church; Robert A H Surtees; Andrew J Lees; Jane E Adcock; Brian Harding; Brian G R Neville; Gavin Giovannoni
Journal:  Brain       Date:  2003-10-21       Impact factor: 13.501

  4 in total
  2 in total

1.  Expressive aphasia as a presentation of encephalitis with Bartonella henselae infection in an immunocompetent adult.

Authors:  Carla B Marienfeld; Daniel B Dicapua; Gordon K Sze; Jonathan M Goldstein
Journal:  Yale J Biol Med       Date:  2010-06

2.  Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes.

Authors:  Robert Lopez-Alberola; Michael Georgiou; George N Sfakianakis; Carlos Singer; Spyridon Papapetropoulos
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.